UBASH3A and breast cancer: Interestingly, although BC showed a lower phosphatase inhibition ratio to STS2 than to STS1 (Figure 1E), its binding to STS2 might be stronger than to STS1, as the migration time of the STS2 protein peak delayed further behind than STS1 when BC was added.